The Biosimilars and Biobetters 2017 is a conference dedicated to the latest updates on regulation, strategies for market access and commercial success.
The Biosimilars and Biobetters 2017 covers topics such as:
- Latest innovative strategies to clinical trial design
- The regulatory challenges facing biosimilars including the latest interchangeability guidelines
- Biosimilars and innovator products on the market
- Market access and optimal pricing for new biosimilars
- The ongoing problems still facing biosimilar drug development
- Challenges and potential solutions to in IP laws, exclusivity and HCP acceptance
The Biosimilars and Biobetters 2017 brings together senior attendees from:
- Follow on Biologics/Follow on Proteins/Biosimilars
- Biopharmaceuticals/ Biotherapeutics
- Legal and Regulatory Affairs
- Biologics/Biotechnology/ Biogenerics
- Pricing and Reimbursement
- Intellectual Property
- Regulatory Compliance
- Clinical operations
- Drug Safety & Risk Management
- Pharmacovigilance
- Drug Development
- Quality Affairs/ Quality Control
- Portfolio Management
- Research & Development
- Commercial Affairs and Strategic Planning
- Business Development